Back to
VOYA INVESTMENT MANAGEMENT LLC
AIMT9 quarters
Position history for
VOYA INVESTMENT MANAGEMENT LLC's holdings in AIMMUNE THERAPEUTICS INC
As of its Q3 2020 13F, Voya Investment Management held 15,977 shares of AIMT (Aimmune Therapeutics), worth $550,000. Voya Investment Management's 13F filings listed AIMT from Q4 2018 to Q3 2020, 8 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$430,000
Total Shares Change
-17,985
Quarter-by-Quarter History
Other major holders of AIMT: PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Pentwater Capital Management LP